Australia markets close in 4 hours 12 minutes

NanoString Technologies, Inc. (NSTG)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
0.1053-0.0630 (-37.43%)
At close: 04:00PM EDT

NanoString Technologies, Inc.

530 Fairview Avenue North
Seattle, WA 98109
United States
206 378 6266

IndustryMedical Instruments & Supplies
Full-time employees550

Key executives

NameTitlePayExercisedYear born
Mr. R. Bradley GrayCEO, President & Director1.06MN/A1977
Mr. K. Thomas Bailey M.B.A.Chief Financial Officer637.41kN/A1969
Dr. Joseph M. Beechem Ph.D.Chief Scientific Officer and Senior VP of Research & Development637.41kN/A1958
Mr. Mark A. WinhamSenior Vice President of OperationsN/AN/AN/A
Mr. Douglas S. FarrellVice President of Investor Relations & Corporate CommunicationsN/AN/AN/A
Ms. Kathryn Surace-SmithSenior VP of Human Resources & Legal Affairs and Corporate SecretaryN/AN/A1959
Elizabeth Schneider Ph.D.Senior Global Marketing ManagerN/AN/AN/A
Dr. Philippa Webster Ph.D.Senior Principal ScientistN/AN/AN/A
Mr. Todd GarlandChief Commercial OfficerN/AN/A1970
Praveer SharmaField Application ScientistN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


NanoString Technologies, Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter Pro and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, cartridges, ancillary reagents, tips and reagent plates to setup and process samples in instruments; and Prosigna in vitro diagnostic kits. The company is also developing GeoMx DSP system to enable the field of spatial biology. It has collaboration with Lam Research Corporation for the development of NGS sequencing platform and related assays; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer, as well as collaboration with Stanford Medicine, Acrobat Genomics, and Illumina Accelerator to discover new drug targets for gene editing-based therapeutics. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington. On February 4, 2024, NanoString Technologies, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Corporate governance

NanoString Technologies, Inc.’s ISS governance QualityScore as of 1 February 2024 is 9. The pillar scores are Audit: 6; Board: 5; Shareholder rights: 7; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.